摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethylene glycol mono-tert.-octyl ether | 6193-78-8

中文名称
——
中文别名
——
英文名称
Ethylene glycol mono-tert.-octyl ether
英文别名
2-(2-Methylheptan-2-yloxy)ethanol
Ethylene glycol mono-tert.-octyl ether化学式
CAS
6193-78-8
化学式
C10H22O2
mdl
——
分子量
174.283
InChiKey
PEBUZCNVNWGPAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • HOLLOW FIBER MEMBRANE FOR BLOOD TREATMENT AND HOLLOW FIBER MEMBRANE-TYPE BLOOD TREATMENT APPARATUS
    申请人:Asahi Kasei Medical Co., Ltd.
    公开号:EP2719408A1
    公开(公告)日:2014-04-16
    [Problem to be Solved] It is intended to obtain a hollow fiber membrane for blood processing that has high membrane performance, can reduce leak misdetection, is excellent in antioxidative performance and blood compatibility, carries a low risk of hydrophilic polymer elution or a leak from hollow fibers, is easy to prime, and has highly stable permeability in a harsh environment. [Solution] The present invention provides a hollow fiber membrane for blood processing, containing a hydrophilic polymer, a polysulfone-based resin, and a fat-soluble vitamin, wherein a content A of the hydrophilic polymer, which is a mass ratio of the hydrophilic polymer to a total mass of the hydrophilic polymer and the polysulfone-based resin in a whole of the hollow fiber membrane for blood processing, is 3% by mass or larger and 10% by mass or smaller, an abundance ratio B of the hydrophilic polymer, which is a mass ratio of the hydrophilic polymer to the total mass of the hydrophilic polymer and the polysulfone-based resin in an inner surface of the hollow fiber membrane for blood processing, is 35% by mass or larger and 50% by mass or smaller, and an abundance of the fat-soluble vitamin in an entire surface of the hollow fiber membrane for blood processing is 0.5 mg or larger and 25 mg or smaller based on 1 g of the hollow fiber membrane.
    [有待解决的问题] 旨在获得一种用于血液处理的中空纤维膜,该膜具有较高的膜性能,可减少泄漏误检,抗氧化性能和血液相容性优异,亲性聚合物洗脱或中空纤维泄漏的风险较低,易于填料,并且在恶劣环境中具有高度稳定的渗透性。 [解决方案] 本发明提供了一种用于血液处理的中空纤维膜,它含有亲性聚合物、聚砜基树脂和脂溶性维生素,其中 亲性聚合物的含量 A,即亲性聚合物与血液处理用中空纤维膜整体中亲性聚合物和聚砜基树脂总质量的质量比,大于等于 3%,小于等于 10%、 亲性聚合物的丰度比 B(即血液处理用中空纤维膜内表面中亲性聚合物与亲性聚合物和聚砜基树脂总质量的质量比)为 35% (以质量为单位)或更大,50% (以质量为单位)或更小,以及 以 1 克中空纤维膜为基准,血液处理用中空纤维膜整个表面中脂溶性维生素的丰度为 0.5 毫克或更大,25 毫克或更小。
  • Polyoxymethylene resin composition and moldings thereof
    申请人:Horio Mitsuhiro
    公开号:US20070129484A1
    公开(公告)日:2007-06-07
    A polyoxymethylene resin composition which comprises (A) a polyoxymethylene resin, (B) a polymer having at least one block made of a hydrogenated aromatic vinyl/conjugated diene random copolymer having the main dispersion peak of tan δ at 60° C. or below in the viscoelastic spectrum, and, if necessary, (C) a polyolefin resin with the provisos that the amount of (A) is 10 to 99.5 parts by weight and the total amount of (B) and (C) is 0.5 to 90 parts by weight, each per 100 parts by weight of the sum of (A), (B) and (C) and that the (B)/(C) weight ratio is 100/0 to 20/80.
  • US4190727A
    申请人:——
    公开号:US4190727A
    公开(公告)日:1980-02-26
  • US6875812B1
    申请人:——
    公开号:US6875812B1
    公开(公告)日:2005-04-05
查看更多